RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
…
Rockwood Research

Corporate filings · Event Monitor · Free for all

← Back

NEUROCRINE BIOSCIENCES INC

NBIX

Biological Products, (No Diagnostic Substances) · SIC 2836 · CIK 0000914475

SHARE:XLINKEDINEMAIL
Revenue FY2025
$2.86B
Net Income
$0.48B
EPS (Basic)
$4.81
Net Margin
16.7%
ROE
14.7%
Total Equity
$3.25B
Shares Out
102M

NEUROCRINE BIOSCIENCES INC — Biological Products, (No Diagnostic Substances). Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2009–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Revenue & Net Income (10Y)

Margin Trends

Investor Ownership · 5 funds in our universe

FundPosition Value% of AUMQoQ ChgWeight
Renaissance Technologies
Renaissance Technologies
$393.7M
0.4%
(3.4%)
Dodge & Cox
Dodge & Cox
$941.2M
0.2%
+2.3%
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
$30.2M
0.1%
+105.1%
Bridgewater Associates
Bridgewater Associates
$34.7M
0.0%
+38.8%
Motley Fool Asset Management
Motley Fool Asset Management
$0.4M
0.0%
+37.1%

Insider Transactions

Reading stored insider transactions…